ArticleLeukemia2019
Response to the Commentary on "Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma".
Giovanni Barosi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it